Cargando…

Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience

BACKGROUND: The new World Health Organization (WHO) classification system proposed a cell lineage-based classification scheme for pituitary adenomas in which transcription factors (TFs) play a major role as key classifiers. We aimed to evaluate clinical relevance of the new classification system in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Seung Woo, Kim, Se Hoon, Lim, Seung Hoon, Lee, Eun Jig, Kim, Sun Ho, Ku, Cheol Ryong, Kim, Eui Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476031/ https://www.ncbi.nlm.nih.gov/pubmed/34589436 http://dx.doi.org/10.3389/fonc.2021.739290

Ejemplares similares

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant
por: Ku, Cheol Ryong, et al.
Publicado: (2021)

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
por: Kim, Junhyung, et al.
Publicado: (2019)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

Dexamethasone suppression for (18)F-FDG PET/CT to localize ACTH-secreting pituitary tumors
por: Kim, Kyungwon, et al.
Publicado: (2023)

Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
por: Kim, Daham, et al.
Publicado: (2019)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
por: Ku, Cheol Ryong, et al.
Publicado: (2020)

Functional Restoration of Pituitary after Pituitary Allotransplantation into Hypophysectomized Rats
por: Choi, Jai Ho, et al.
Publicado: (2021)

Development and Validation of a Prognostic Model for Post-Operative Recurrence of Pituitary Adenomas
por: Lu, Liang, et al.
Publicado: (2022)

Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality
por: Kim, Eui Hyun, et al.
Publicado: (2023)

Sprouting Angiogenesis in Human Pituitary Adenomas
por: Zhou, Jie, et al.
Publicado: (2022)

Identification of the Extradural and Intradural Extension of Pituitary Adenomas to the Suprasellar Region: Classification, Surgical Strategies, and Outcomes
por: Yang, YouQing, et al.
Publicado: (2021)

Group B Streptococcus Meningitis Presenting as the Initial Symptom of a Recurrent Pituitary Adenoma
por: Kang, Kyung Wook, et al.
Publicado: (2018)

Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer
por: Kim, Daham, et al.
Publicado: (2022)

Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Dai, Congxin, et al.
Publicado: (2021)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
por: Kim, Kyungwon, et al.
Publicado: (2023)

No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Antidiabetic Effects of NRDT50, the Enzyme Composition for Regulating Sugar Metabolism, in Db/db Mice
por: Kim, Daham, et al.
Publicado: (2021)

The Application of Artificial Intelligence and Machine Learning in Pituitary Adenomas
por: Dai, Congxin, et al.
Publicado: (2021)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

Adrenocorticotropic Hormone-Secreting Esthesioneuroblastoma with Ectopic Cushing's Syndrome
por: Chung, Young Soo, et al.
Publicado: (2020)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
por: Lee, Youngki, et al.
Publicado: (2014)

Progress in the Diagnosis and Classification of Pituitary Adenomas
por: Syro, Luis V., et al.
Publicado: (2015)

THU553 Anti-tumor Effect Of Rosiglitazone Via Upregulating 15-PDGH In Prolactin Secreting Adenoma
por: Kang, Chan Woo, et al.
Publicado: (2023)

Refractory pituitary adenoma: a novel classification for pituitary tumors
por: Dai, Congxin, et al.
Publicado: (2016)

Response: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab 2016;31:328-35, Cheol Ryong Ku et al.)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Pseudocapsule-Based Resection for Pituitary Adenomas via the Endoscopic Endonasal Approach
por: Zhou, Yuefei, et al.
Publicado: (2022)

Expression pattern of non-coding RNAs in non-functioning pituitary adenoma
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Endoscopic transorbital approach to the cavernous sinus: Cadaveric anatomy study and clinical application ((‡)SevEN-009)
por: Jung, In-Ho, et al.
Publicado: (2022)

Radiological Knosp, Revised-Knosp, and Hardy–Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases
por: Araujo-Castro, Marta, et al.
Publicado: (2022)

Cyst Type Differentiates Rathke Cleft Cysts From Cystic Pituitary Adenomas
por: Tavakol, Sherwin, et al.
Publicado: (2021)

The Clinical and Pathological Characteristics of Refractory Pituitary Adenomas: A Single Center Experience
por: Liu, Xiaohai, et al.
Publicado: (2022)

Application of Convolutional Neural Network in the Diagnosis of Cavernous Sinus Invasion in Pituitary Adenoma
por: Fang, Yi, et al.
Publicado: (2022)

Visual field improvement after endoscopic transsphenoidal surgery in patients with pituitary adenoma
por: Ji, Xiaoyu, et al.
Publicado: (2023)

Alterations of the Gut Microbiome in Patients With Pituitary Adenoma
por: Hu, Jinxian, et al.
Publicado: (2022)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

Effect of Treatment Modality on the Hypothalamic–Pituitary Function of Patients Treated with Radiation Therapy for Pituitary Adenomas: Hypothalamic Dose and Endocrine Outcomes
por: Elson, Andrew, et al.
Publicado: (2014)

Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas : Single Institutional Experience of 14 Consecutive Cases
por: Byun, Joonho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9955d6pfi4t64grjpmc44b58n